WT1 expression and hemihypertrophy in congenital mesoblastic nephroma

被引:1
作者
Abosoudah, Ibraheem [2 ]
Ngan, Bo-Yee [1 ]
Grant, Ronald [2 ]
Weitzman, Sheila [2 ]
机构
[1] Univ Toronto, Hosp Sick Children SickKids, Dept Pediat Lab Med, Div Pathol, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Div Pediat Hematol Oncol, Toronto, ON M5G 1X8, Canada
关键词
congenital mesoblastic nephroma; CMN; hemihypertrophy; infant; WTI; renal neoplasms; Beckwith-Wiedemann syndrome;
D O I
10.1097/MPH.0b013e31817eb80a
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Congenital mesoblastic nephroma (CMN) is a rare primary pediatric renal tumor occurring predominantly in infants. There is no known association between CMN and WT1 gene expression and the association of hemihypertrophy and CMN is not well known. We report an infant with isolated hemihypertrophy and WT1-positive CMN, and the results of WT1 immunostaining in 13 other patients with CMN diagnosed over 14 years at SickKids. Of the 14 total patients 3 had positive nuclear immunostaining for WT1. Two patients also expressed WT1 RNA by reverse transcription-polymerase chain reaction. In conclusion, contrary to previous reports, WT1 may be expressed in CMN and CMN can be associated with hemihypertrophy in the absence of Beckwith-Wiedemann syndrome.
引用
收藏
页码:768 / 771
页数:4
相关论文
共 31 条
[1]   ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization [J].
Adem, C ;
Gisselsson, D ;
Dal Cin, P ;
Nascimento, AG .
MODERN PATHOLOGY, 2001, 14 (12) :1246-1251
[2]   Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors [J].
Bjornsson, Hans T. ;
Brown, Lindsey J. ;
Fallin, M. Danielle ;
Rongione, Michael A. ;
Bibikova, Marina ;
Wickham, Eliza ;
Fan, Jian-Bing ;
Feinberg, Andrew P. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (16) :1270-1273
[3]   Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry [J].
DeBaun, MR ;
Tucker, MA .
JOURNAL OF PEDIATRICS, 1998, 132 (03) :398-400
[4]   Mesoblastic nephroma - A report from the Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) [J].
Furtwaengler, R ;
Reinhard, H ;
Leuschner, L ;
Schenk, JP ;
Goebel, U ;
Claviez, A ;
Kulozik, A ;
Zoubek, A ;
von Schweinitz, D ;
Graf, N .
CANCER, 2006, 106 (10) :2275-2283
[5]  
HEDBORG F, 1994, AM J PATHOL, V145, P802
[6]   THERAPY AND OUTCOME IN 51 CHILDREN WITH MESOBLASTIC NEPHROMA - A REPORT OF THE NATIONAL WILMS TUMOR STUDY [J].
HOWELL, CG ;
OTHERSEN, HB ;
KIVIAT, NE ;
NORKOOL, P ;
BECKWITH, JB ;
DANGIO, GJ .
JOURNAL OF PEDIATRIC SURGERY, 1982, 17 (06) :826-831
[7]  
Hoyme HE, 1998, AM J MED GENET, V79, P274, DOI 10.1002/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.3.CO
[8]  
2-K
[9]  
Knezevich SR, 1998, CANCER RES, V58, P5046
[10]   High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia [J].
Lapillonne, H ;
Renneville, A ;
Auvrignon, A ;
Flamant, C ;
Blaise, A ;
Perot, C ;
Lai, JC ;
Ballerii, P ;
Mazingue, F ;
Fasola, S ;
Dehée, A ;
Bellman, F ;
Adam, M ;
Labopin, M ;
Douay, L ;
Leverger, G ;
Preudhomme, C ;
Landman-Parker, J .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1507-1515